CN116421485A - Low-irritation cosmetic - Google Patents
Low-irritation cosmetic Download PDFInfo
- Publication number
- CN116421485A CN116421485A CN202310025885.XA CN202310025885A CN116421485A CN 116421485 A CN116421485 A CN 116421485A CN 202310025885 A CN202310025885 A CN 202310025885A CN 116421485 A CN116421485 A CN 116421485A
- Authority
- CN
- China
- Prior art keywords
- mass
- preservative
- irritation
- low
- cosmetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 44
- 230000002335 preservative effect Effects 0.000 claims abstract description 59
- 239000003755 preservative agent Substances 0.000 claims abstract description 58
- 230000007794 irritation Effects 0.000 claims abstract description 29
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 229960005323 phenoxyethanol Drugs 0.000 claims abstract description 21
- 229940015975 1,2-hexanediol Drugs 0.000 claims abstract description 16
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims abstract description 16
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 claims abstract description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 25
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 claims description 23
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims description 16
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 13
- 238000004519 manufacturing process Methods 0.000 claims description 12
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims description 11
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims description 11
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims description 11
- 229940036350 bisabolol Drugs 0.000 claims description 11
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims description 11
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 6
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 claims description 6
- 229960002446 octanoic acid Drugs 0.000 claims description 6
- 230000002421 anti-septic effect Effects 0.000 abstract description 13
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 4
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 32
- 230000000052 comparative effect Effects 0.000 description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- 239000008213 purified water Substances 0.000 description 20
- 239000003906 humectant Substances 0.000 description 18
- 239000000839 emulsion Substances 0.000 description 17
- 239000004094 surface-active agent Substances 0.000 description 17
- 206010040880 Skin irritation Diseases 0.000 description 16
- 231100000475 skin irritation Toxicity 0.000 description 16
- 230000036556 skin irritation Effects 0.000 description 16
- 241000894006 Bacteria Species 0.000 description 15
- 239000000203 mixture Substances 0.000 description 14
- 239000003381 stabilizer Substances 0.000 description 14
- 238000011156 evaluation Methods 0.000 description 12
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 12
- 239000003921 oil Substances 0.000 description 11
- 210000003491 skin Anatomy 0.000 description 11
- 238000010998 test method Methods 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 9
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 9
- 229960002216 methylparaben Drugs 0.000 description 9
- 230000007797 corrosion Effects 0.000 description 8
- 238000005260 corrosion Methods 0.000 description 8
- 229940087068 glyceryl caprylate Drugs 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 230000014509 gene expression Effects 0.000 description 7
- 230000003833 cell viability Effects 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- -1 alkane diols Chemical class 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- 239000003002 pH adjusting agent Substances 0.000 description 5
- 230000037307 sensitive skin Effects 0.000 description 5
- 206010015150 Erythema Diseases 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 231100000321 erythema Toxicity 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 108090000695 Cytokines Proteins 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 102000004889 Interleukin-6 Human genes 0.000 description 2
- 108090001005 Interleukin-6 Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033733 Papule Diseases 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 2
- 229940100524 ethylhexylglycerin Drugs 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 2
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- VUWCWMOCWKCZTA-UHFFFAOYSA-N 1,2-thiazol-4-one Chemical class O=C1CSN=C1 VUWCWMOCWKCZTA-UHFFFAOYSA-N 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- 229940035437 1,3-propanediol Drugs 0.000 description 1
- CRBJBYGJVIBWIY-UHFFFAOYSA-N 2-isopropylphenol Chemical compound CC(C)C1=CC=CC=C1O CRBJBYGJVIBWIY-UHFFFAOYSA-N 0.000 description 1
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- UQPLZHUFLPDORW-UHFFFAOYSA-N 2-phenylphenol;sodium Chemical compound [Na].OC1=CC=CC=C1C1=CC=CC=C1 UQPLZHUFLPDORW-UHFFFAOYSA-N 0.000 description 1
- VPWNQTHUCYMVMZ-UHFFFAOYSA-N 4,4'-sulfonyldiphenol Chemical class C1=CC(O)=CC=C1S(=O)(=O)C1=CC=C(O)C=C1 VPWNQTHUCYMVMZ-UHFFFAOYSA-N 0.000 description 1
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 description 1
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- LEGVTAFKUDAZRE-UHFFFAOYSA-N 5-ethylnonane-1,2,3-triol Chemical compound CCCCC(CC)CC(O)C(O)CO LEGVTAFKUDAZRE-UHFFFAOYSA-N 0.000 description 1
- GOZMBJCYMQQACI-UHFFFAOYSA-N 6,7-dimethyl-3-[[methyl-[2-[methyl-[[1-[3-(trifluoromethyl)phenyl]indol-3-yl]methyl]amino]ethyl]amino]methyl]chromen-4-one;dihydrochloride Chemical compound Cl.Cl.C=1OC2=CC(C)=C(C)C=C2C(=O)C=1CN(C)CCN(C)CC(C1=CC=CC=C11)=CN1C1=CC=CC(C(F)(F)F)=C1 GOZMBJCYMQQACI-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000197194 Bulla Species 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- 231100000960 LabCyte EPI-MODEL 24 Toxicity 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- LLEMOWNGBBNAJR-UHFFFAOYSA-N biphenyl-2-ol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- ZFSXZJXLKAJIGS-UHFFFAOYSA-N halocarban Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(NC(=O)NC=2C=CC(Cl)=CC=2)=C1 ZFSXZJXLKAJIGS-UHFFFAOYSA-N 0.000 description 1
- 229950006625 halocarban Drugs 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 1
- 238000012009 microbiological test Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 108091008695 photoreceptors Proteins 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
Abstract
The present invention provides a preservative accelerator and a low-irritation cosmetic containing the same, wherein the preservative accelerator does not use a preservative which has high preservative property but can induce inflammatory reaction to have high irritation, but has higher preservative property by combining a preservative which has low preservative property but has low irritation. The antiseptic promoter contains at least 3 or more antiseptic agents other than phenoxyethanol, parahydroxybenzoate and 1, 2-hexanediol, and the low-irritation cosmetic contains the antiseptic promoter and is free of phenoxyethanol, parahydroxybenzoate and 1, 2-hexanediol.
Description
Technical Field
The present invention relates to a preservative accelerator, and a method for producing a low-irritation cosmetic or a low-irritation cosmetic containing the preservative accelerator.
Background
Conventionally, various preservatives have been used in compositions such as cosmetics, pharmaceuticals, and medical skin care products (external products for medical use) in order to maintain the preservability of the product. Examples of such preservatives include parahydroxybenzoates (parabens), phenoxyethanol, benzoic acid and salts thereof, salicylic acid and salts thereof, polyols, and the like.
Among these, parahydroxybenzoic acid esters and phenoxyethanol are frequently used as components having excellent effectiveness in cosmetics and the like.
However, formulations which have been made superior in preservative properties by using monomers such as parabens have been accompanied by irritation to consumers of sensitive skin. Therefore, studies have been made on selection of preservatives which are less irritating while retaining the preservative property or on improving the effect of the preservatives while reducing the amount of the preservatives to be used.
Specifically, a method of combining a plurality of preservatives to reduce the amount of the preservatives used has been studied.
Patent document 1 describes a cosmetic excellent in safety and improved in corrosion resistance by using 1, 3-butanediol and 1, 2-pentanediol in combination.
Patent document 2 describes a preservative composition which is excellent in preservative property and can suppress skin irritation by blending 1, 3-propanediol into parahydroxybenzoates or phenoxyethanol.
In recent years, as consumer awareness of safety increases, cosmetics and medical skin care products having low irritation to skin and low allergy are demanded, and thus low irritation cosmetics excellent in corrosion resistance are demanded.
Prior art literature
Patent literature
Patent document 1: japanese patent laid-open No. 11-335258
Patent document 2: japanese patent laid-open publication No. 2005-15401
Disclosure of Invention
However, no cosmetic has been found so far which does not contain phenoxyethanol, parahydroxybenzoate, 1, 2-hexanediol, or the like which are excellent in preservative properties by a monomer, but is excellent in preservative properties and low in irritation.
Accordingly, the present invention provides a preservative which does not use a preservative having high preservative properties but causes an inflammatory reaction to be induced and is accompanied by high irritation, and a low-irritation cosmetic containing the same, and which has high preservative properties by combining a preservative having low preservative properties but also having low irritation.
Namely, the present invention provides a preservative accelerator containing at least 3 or more preservatives other than phenoxyethanol, p-hydroxybenzoate and 1, 2-hexanediol, and a low-irritation cosmetic containing the preservative accelerator, which does not contain phenoxyethanol, p-hydroxybenzoate and 1, 2-hexanediol.
The preservative accelerator of the present invention has excellent preservative properties and is accompanied by low skin irritation by combining 3 or more kinds selected from the group consisting of pentanediol, ethylhexyl glycerol, 1, 3-Butanediol (BG), caprylic acid glyceride, and bisabolol, among preservatives in amounts that do not exhibit sufficient preservative properties when used alone, except phenoxyethanol, p-hydroxybenzoate, and 1, 2-hexanediol. The effect of the present invention is also effective in all cosmetics such as lotions and emulsion compositions containing the preservative.
Detailed Description
The preservative in the present invention is a substance used for the purpose of preventing the proliferation of microorganisms such as bacteria and mold, and generally includes a substance having bactericidal or antibacterial properties in addition to the substance used as a preservative. In the present invention, the term "antiseptic" means an effect of reducing the number of bacteria and all contaminant microorganisms such as bacteria and yeasts.
Examples of the preservative include parahydroxybenzoates (parahydroxybenzoates such as methyl parahydroxybenzoate, ethyl parahydroxybenzoate, propyl parahydroxybenzoate, butyl parahydroxybenzoate, etc.), which are used in cosmetics and medical skin care products; phenoxyethanol; alkane diols such as 1, 2-pentanediol (pentanediol), 1, 2-hexanediol, 1, 2-octanediol, and 1, 3-butanediol; alkyl glycerol ethers such as 2-ethylhexyl glycerol ether (ethylhexyl glycerol); fatty acid glycerides such as caprylic acid glyceride, capric acid glyceride, and (caprylic/capric acid) glyceride; salicylic acid; sodium benzoate; isothiazolinone derivatives such as methyl chloroisothiazolinone and methyl isothiazolinone; imidazolinesUrea; dehydroacetic acid and salts thereof; phenols; halogenated bisphenols such as triclosan, acid amides, and quaternary ammonium salts; triclocarban, zinc pyrithione, benzalkonium chloride, benzethonium chloride, sorbic acid, chlorhexidine gluconate, halocarban, hexachlorophene, hinokitiol; phenol, isopropyl phenol, cresol, thymolOther phenols such as p-chlorophenol, phenylphenol, and sodium phenylphenol; phenethyl alcohol, photoreceptors, antibacterial zeolite, and silver ions are preferable examples.
The present inventors have found that the presence of phenoxyethanol, parahydroxybenzoate and 1, 2-hexanediol among the above preservatives, in particular, makes the expression of inflammatory cytokine genes inducing inflammatory reaction remarkable, and have conducted studies on low-irritation cosmetics not containing these preservatives.
Among the above preservatives, at least 3 or more selected from pentanediol, ethylhexyl glycerol, 1, 3-butanediol, caprylic acid glyceride, and bisabolol are particularly preferably used in combination, from the viewpoint of excellent preservative properties and low skin irritation.
In the present invention, the cosmetic includes, for example, base cosmetics such as lotions, essences, emulsions, creams, facial masks, sun blocks, etc., make-up cosmetics such as foundation, powder, foundation, mascara, eyeliner, eye shadow, lipstick, concealer, blush, nail polish, etc., hair cosmetics such as shampoos, conditioners, hair styling agents, etc., body cleaners such as body washes, make-up remover, facial cleanser, etc., and the topical compositions as medical skin care products may be applied.
The pentanediol, ethylhexyl glycerol, 1, 3-butanediol, caprylic acid glyceride, and bisabolol used in the present invention may be blended with commercially available products.
When the pentanediol is contained in the cosmetic, the pentanediol is preferably 0.1 to 5% by mass, more preferably 0.5 to 4% by mass, and particularly preferably 1 to 3% by mass in the whole cosmetic. The ethylhexyl glycerin is preferably 0.005 to 0.5% by mass, more preferably 0.01 to 0.4% by mass, and particularly preferably 0.05 to 0.3% by mass in the whole cosmetic. The 1, 3-butanediol is preferably 1.0 to 30.0% by mass, more preferably 3.0 to 20.0% by mass, and particularly preferably 5.0 to 15.0% by mass in the whole cosmetic. The content of the caprylic acid glyceride in the whole cosmetic is preferably 0.05 to 1.0% by mass, more preferably 0.1 to 0.5% by mass, and particularly preferably 0.2 to 0.4% by mass. The amount of bisabolol in the whole cosmetic is preferably 0.05 to 1.0% by mass, more preferably 0.1 to 0.8% by mass, and particularly preferably 0.2 to 0.6% by mass.
The low-irritation cosmetic of the present invention may suitably contain components such as moisturizer, oil, surfactant, thickener, pH adjuster, chelating agent, antioxidant, neutralizer, bioactive component, salt, powder (pigment ), ultraviolet absorber, perfume, etc., and may contain all of the components generally commercially available.
The "preservative accelerator" mentioned in the present invention means a substance which gives excellent preservative properties by combining 3 or more of preservatives in amounts that do not exhibit sufficient preservative properties when used alone and is accompanied by low skin irritation, and the "low-irritation cosmetic" means a cosmetic having low skin irritation.
Examples
[ expression of inflammatory cytokine Gene by preservative ]
(1) (study of test concentration) test method
Human epidermal keratinocytes were cultured the day before, and the concentrations of the respective preservatives (methylparaben, pentanediol, 1, 2-hexanediol, ethylhexyl glycerol, phenoxyethanol) were adjusted and added the day after. After 24 hours, cell viability was calculated by MTT assay and is shown in table 1. The concentration at which the cell viability was 70% or more was determined to be the test concentration for gene expression verification (methylparaben: 0.1 mass%, pentanediol: 0.6 mass%, 1, 2-hexanediol: 0.4 mass%, ethylhexyl glycerol: 0.015 mass%, phenoxyethanol: 0.2 mass%).
TABLE 1
(2) (verification of Gene expression) test method
Human epidermal keratinocytes were cultured the previous day, and each preservative (methylparaben, pentanediol, 1, 2-hexanediol, ethylhexyl glycerol, phenoxyethanol) was added to the above test concentration the next day. After 6 hours and 18 hours of culture, the cells were recovered and RNA was extracted. Then, cDNA was prepared, and the expression of inflammatory cytokine genes (IL-6, IL-8, IL-1β, TNF-. Alpha.) was confirmed by real-time PCR, and the gene expression amounts were shown in Table 2.
TABLE 2
6h treatment: n=2, mean±sd
And (3) 18h of treatment: n=3, P < 0.05, vs control group, dunnett, mean±sd
From the results shown in Table 2, it was clearly confirmed that phenoxyethanol, 1, 2-hexanediol significantly increased the expression of IL-6, TNF- α.
This means that in particular phenoxyethanol, 1, 2-hexanediol are factors which lead to inflammation.
[ preservative test ]
Preservative efficacy was determined by the Nihon Kolmar preservation efficacy test method using 7 mixed bacterial inoculations (bacteria/yeast). Table 3 shows the difference between the Nihon Kolmar preservation efficacy test method and the JP method and the ISO method of the general preservative test method. The control formula used in the Nihon Kolmar preservation efficacy test method meets the qualification standard of the JP method and the ISO method.
TABLE 3
< 1. Test bacterium >)
Bacterial 6/Yeast 1 (total 7)
After properly culturing each test bacterium, a bacterium suspension was prepared.
All the bacterial suspensions were mixed in equal amounts to prepare 7 mixed bacterial suspensions.
< 2. Sample preparation and Vaccination >
(1) 20g of the sample is taken and placed in a suitable sterile container.
(2) Samples were inoculated with 0.2mL (1/100 of the sample) of 7 mixed bacterial suspensions.
(3) The samples were stirred to uniformly disperse the 7 mixed bacterial suspensions.
(4) Samples were stored at 32 ℃ until the end of the test.
< 3 test method >)
(1) Starting from the inoculation day of the 7 mixed bacterial suspensions, sampling is carried out in principle after days 1, 4, 7, 11,
microbiological tests were performed by agar plates.
(2) The cells were cultured at 32℃for 3 days (or more) and the number of the cells was measured.
(3) The number of residual bacteria in each 1g of the sample was converted from the number of bacteria measured.
When the number of residual bacteria is less than or equal to the detection limit, the culture medium is transferred from the next test to the liquid culture method.
(4) In the liquid culture method, when the test bacteria are not detected, the test is ended and compared with the preservative judgment standard.
< 4. Antiseptic criterion >
The corrosion resistance was equal to or higher than that of the control formula (meeting the standard of JP and ISO methods of the general test method) described below.
The formula of the control group: toning lotion
(composition)
Methyl parahydroxybenzoate: 0.14 mass%
1, 3-butanediol: 0.01 mass%
Humectant: 12.99% by mass
pH regulator: 0.17 mass%
Purified water: allowance of
(manufacturing method)
A: mixing purified water, humectant, methyl parahydroxybenzoate and 1, 3-butanediol at 80deg.C, and heating to dissolve.
B: the A was cooled to 35℃and the pH was adjusted with a pH adjustor.
The corrosion resistance test results were classified into the following 4 grades.
Antiseptic criterion
And (3) the following materials: has very strong antiseptic effect (bacteria die 3 days earlier than the control group)
And (2) the following steps: has strong antiseptic effect (the bacteria die in the same day as the control group)
Delta: the antiseptic effect is weak (bacteria die 3 days later than the control group)
X: has no antiseptic effect (no difference with TNTC or no death of bacteria)
TNTC (Too Numerous To Count Duoduo cannot be measured)
(examples 1 to 4, comparative examples 1 to 36): preservative accelerator
The above-mentioned preservative test was performed on an aqueous solution containing only a preservative in purified water shown in table 4 below, and the evaluation results are shown in table 4.
TABLE 4
TNTC (Too Numerous To Count. Duoduo)
B, performing BG:1, 3-butanediol
From the evaluation results of examples and comparative examples, it was determined that examples 1 to 4 obtained excellent corrosion resistance by combining 3 or more kinds of corrosion inhibitors in amounts that did not exhibit sufficient corrosion resistance when used alone.
(examples 5 to 8, comparative examples 37 to 46): cosmetic containing antiseptic promoter
The above-mentioned preservative tests were performed on cosmetics containing a preservative promoter shown in table 5 below, and the evaluation results are shown in table 5.
TABLE 5
TNTC (Too Numerous To Count. Duoduo)
B, performing BG:1, 3-butanediol
From the evaluation results of examples and comparative examples, it was confirmed that the cosmetics containing the preservatives of the combinations of examples 1 to 4 (examples 5 to 8) have excellent preservative properties.
The formulation and manufacturing method of each cosmetic are described below.
Formula of cosmetic water raw material (1)
(composition)
Each preservative: table 5 amount of
And (2) a surfactant: 2.0 mass%
pH regulator: 0.07 mass%
Humectant: 3.0 mass%
Purified water: allowance of
(manufacturing method)
A: mixing purified water, humectant, surfactant, and antiseptic at room temperature.
B: the pH of A is adjusted with a pH adjustor.
Formula of raw material (2) of toning lotion
(composition)
Each preservative: table 5 amount of
And (2) a surfactant: 0.20 mass%
pH regulator: 0.14 mass%
Humectant: 6.30 mass%
Purified water: allowance of
(manufacturing method)
A: mixing purified water, humectant, surfactant and antiseptic at room temperature.
B: the pH of A is adjusted with a pH adjustor.
The formula of the raw materials (3) of the toning lotion comprises: example 5
(composition)
BG:3.00 mass%
Ethylhexyl glycerol: 0.05 mass%
Pentanediol: 3.00 mass%
And (2) a surfactant: 1.30% by mass
Humectant: 13.33 mass%
pH regulator: 0.07 mass%
Tackifier: 0.05 mass%
Purified water: allowance of
(manufacturing method)
A: mixing purified water, humectant, ethylhexyl glycerin, pentanediol and tackifier at 80deg.C, and heating to dissolve.
B: cooling the A to 35 ℃, adding the BG and the surfactant, and uniformly mixing.
C: and (3) regulating the pH of the solution B by using a pH regulator.
Emulsion raw material (1) formula
(composition)
And (3) oil agent: 5.50% by mass
Humectant: 11.00 mass%
Each preservative: table 5 amount of
And (2) a surfactant: 1.00 mass%
Emulsion stabilizer: 0.75 mass%
pH regulator: 0.36 mass%
Purified water: allowance of
(manufacturing method)
A: mixing purified water, antiseptic, humectant and emulsion stabilizer at 80deg.C.
B: the oil agent and the surfactant are uniformly mixed at 80 ℃.
C: the A is added into the B and stirred by a homogenizer.
D: c was cooled to 35 ℃ and pH was adjusted with pH adjuster.
(composition)
Formula of raw material (1) of cream
And (3) oil agent: 9.50% by mass
Humectant: 4.00 mass%
Each preservative: table 5 amount of
And (2) a surfactant: 2.70% by mass
Emulsion stabilizer: 3.79 mass%
pH regulator: 0.04 mass%
Purified water: allowance of
(manufacturing method)
A: purified water, preservatives, humectants, emulsion stabilizers (a portion) were mixed homogeneously at 80 ℃.
B: the oil, surfactant, emulsion stabilizer (remaining) were mixed homogeneously at 80 ℃.
C: the A is added into the B and stirred by a homogenizer.
D: c was cooled to 35 ℃ and pH was adjusted with pH adjuster.
The formula of the cream raw material (2) comprises: example 6
(composition)
BG: 5.50% by mass
Ethylhexyl glycerol: 0.10 mass%
Pentanediol: 2.00 mass%
And (3) oil agent: 26.30 mass%
Humectant: 8.00 mass%
And (2) a surfactant: 3.70 mass%
Emulsion stabilizer: 4.20% by mass
pH regulator: 0.11 mass%
Purified water: allowance of
(manufacturing method)
A: purified water, BG, ethylhexyl glycerol, pentanediol, humectants, and emulsion stabilizers (a portion) were mixed uniformly at 80 ℃.
B: the oil, surfactant, emulsion stabilizer (remaining) were mixed homogeneously at 80 ℃.
C: the A is added into the B and stirred by a homogenizer.
D: c was cooled to 35 ℃ and pH was adjusted with pH adjuster.
The formula of the cream raw material (3) comprises: example 7
(composition)
BG:6.00 mass%
Glyceryl caprylate: 0.20 mass%
Pentanediol: 2.50% by mass
And (3) oil agent: 27.7% by mass
Humectant: 6.0 mass%
And (2) a surfactant: 5.6% by mass
Emulsion stabilizer: 4.22 mass%
pH regulator: 0.07 mass%
Purified water: allowance of
(manufacturing method)
A: purified water, BG, glyceryl caprylate, pentanediol, humectant, and emulsion stabilizer (a portion) were mixed uniformly at 80 ℃.
B: the oil, surfactant, emulsion stabilizer (remaining) were mixed homogeneously at 80 ℃.
C: the A is added into the B and stirred by a homogenizer.
D: c was cooled to 35 ℃ and pH was adjusted with pH adjuster.
The formula of the powder base liquid raw material (1) comprises: example 8
BG:7.00 mass%
Bisabolol: 0.50 mass%
Glyceryl caprylate: 0.05 mass%
And (3) pigment: 16.80 mass%
And (2) a surfactant: 5.00 mass%
Oil-soluble components: 32.90 mass%
Humectant: 3.00 mass%
Emulsion stabilizer: 2.55 mass%
Ultraviolet absorber: 6.95 mass%
Purified water: allowance of
(manufacturing method)
A: uniformly mixing and dissolving the oil agent (part), the ultraviolet absorbent and the caprylic glyceride at 80 ℃.
B: the oil (remainder), the surfactant, the emulsion stabilizer (part), and the pigment were added in this order to the a, and uniformly mixed by dispersion treatment.
C: the humectant, purified water, emulsion stabilizer (remaining) were mixed at room temperature.
D: c and bisabolol were added to B and stirred with a homogenizer.
[ irritation test ]: irritation test
In the verification, the specimens of examples and comparative examples were used on the inner side of the forearm of 5 persons who were considered sensitive skin, and the skin conditions before, immediately after, after 6 hours, and after 24 hours were used as a questionnaire to determine whether or not the skin was stimulated (hot and spicy feeling).
The results of the irritation test were classified into the following 4 grades.
Irritation determination criterion
And (3) the following materials: no skin irritation (no person feeling irritation after coating)
O: skin irritation is weak (1 out of 5 after coating feel irritation)
Delta: the skin irritation is slightly strong (2-3 out of 5 coated feel irritation)
X: the skin irritation is strong (4-5 out of 5 coated feel irritation)
Examples 1 to 4 and comparative examples 1 to 36, the corrosion inhibitors were low in irritation
The above-mentioned irritation test was performed on an aqueous solution containing only a preservative in purified water shown in table 6 below, and the evaluation results are shown in table 6.
TABLE 6
Before coating | After coating | After 6 hours | After 24 hours | Stimulation determination | ||
Comparative example 2 | 0.05 mass% ethylhexyl glycerol | 0 | 0 | 0 | 0 | ◎ |
Comparative example 3 | 0.1% by mass of ethylhexyl glycerol | 0 | 3 | 2 | 0 | △ |
Comparative example 8 | 3.0% by mass of pentanediol | 0 | 0 | 0 | 0 | ◎ |
Comparative example 10 | 5.0% by mass of pentanediol | 0 | 2 | 1 | 0 | △ |
Comparative example 33 | 3.0 mass% BG | 0 | 0 | 0 | 0 | ◎ |
Comparative example 34 | 5.0 mass% BG | 0 | 0 | 0 | 0 | ◎ |
Comparative example 12 | 10.0 mass% BG | 0 | 1 | 1 | 0 | ○ |
Comparative example 13 | 20.0 mass% BG | 0 | 2 | 1 | 0 | △ |
Comparative example 17 | 0.25 mass% phenoxyethanol | 0 | 1 | 0 | 0 | ○ |
Comparative example 20 | 0.5 mass% phenoxyethanol | 0 | 3 | 1 | 0 | △ |
Comparative example 22 | 0.1% by mass of methyl parahydroxybenzoate | 0 | 1 | 0 | 0 | ○ |
Comparative example 24 | 0.2 mass% of methyl parahydroxybenzoate | 0 | 3 | 2 | 0 | △ |
Comparative example 25 | 0.1% by mass of glyceryl caprylate | 0 | 0 | 0 | 0 | ◎ |
Comparative example 26 | 0.2 mass% of glyceryl caprylate | 0 | 0 | 0 | 0 | ◎ |
Comparative example 27 | 0.1 mass% bisabolol | 0 | 0 | 0 | 0 | ◎ |
Comparative example 28 | 0.5 mass% bisabolol | 0 | 1 | 0 | 0 | ○ |
Comparative example 29 | 0.1 mass% bisabolol+5.0 mass% BG | 0 | 0 | 0 | 0 | ◎ |
Comparative example 30 | 0.05 mass% ethylhexyl glycerol+5.0 mass% BG | 0 | 0 | 0 | 0 | ◎ |
Comparative example 31 | 0.2 mass% glyceryl caprylate+5.0 mass% BG | 0 | 0 | 0 | 0 | ◎ |
Comparative example 32 | 0.3 mass% 1, 2-hexanediol+5.0 mass% BG | 0 | 1 | 0 | 0 | ○ |
Comparative example 33 | 0.25 mass% phenoxyethanol+5.0 mass% BG | 0 | 1 | 0 | 0 | ○ |
Comparative example 34 | 2.0 mass% pentanediol+6.0 mass% BG | 0 | 0 | 0 | 0 | ◎ |
Comparative example 35 | 2.5 mass% pentanediol+3.0 mass% BG | 0 | 0 | 0 | 0 | ◎ |
Comparative example 36 | 0.12 mass% methyl parahydroxybenzoate+6.0 mass% BG | 0 | 0 | 0 | 0 | ◎ |
Example 1 | 0.05 mass% ethylhexyl glycerol+3.0 mass% pentanediol+3.0 mass% BG | 0 | 0 | 0 | 0 | ◎ |
Example 2 | 0.1 mass% ethylhexyl glycerol+2.0 mass% pentanediol+5.5 mass% BG | 0 | 0 | 0 | 0 | ◎ |
Example 3 | 0.2 mass% glyceryl caprylate+2.5 mass% pentanediol+6.0 mass% BG | 0 | 0 | 0 | 0 | ◎ |
Example 4 | 0.5 mass% bisabolol+0.05 mass% glyceryl caprylate+7.0 mass% BG | 0 | 0 | 0 | 0 | ◎ |
B, performing BG:1, 3-butanediol
As is clear from the evaluation results of examples and comparative examples, the number of monitors who felt the stimulus in examples 1 to 4 was 0, and the low-irritation was determined.
Examples 5 and 8 Low irritation cosmetic
The above-described irritation test was performed on examples 5 and 8, which are cosmetics containing the preservative according to the present invention shown in table 7 below, and the evaluation results are shown in table 7.
TABLE 7
BG 1, 3-butanediol
As is clear from the evaluation results of examples, the number of monitors who felt the stimulus in examples 5 and 8 was 0, and the low-irritation was determined.
[ irritation test ]: skin model test
Using skin models
J-TEC LabCyte EPI-MODEL 24 well
By evaluating under a condition more severe than the usual test method prescribed in the OECD guidelines, it is possible to detect a stimulus which cannot be detected by healthy skin, and it is said that the sensitive skin which currently occupies most of japanese is set as a presumed sensitive skin model.
(1) Test method
The skin model was transferred to a 24-well plate and cultured in a medium maintained for 1 hour or more. The sample was exposed by adding 50. Mu.L to the epidermis side. After incubation for 24 hours, washing with PBS (-), transferring to MTT-added medium, culturing for 3 hours, and then extracting with isopropanol to obtain the cell viability by measuring absorbance at OD570 nm.
(2) Determination criterion
The stimulation was determined to be not stimulated when the cell viability was greater than 70%, and to be stimulated when the cell viability was not greater than 70%.
Examples 6 and 7 Low irritation cosmetic
The skin model test was performed on examples 6 and 7, which are cosmetics containing the preservative according to the present invention shown in table 8 below, and the evaluation results are shown in table 8.
TABLE 8
From the evaluation results of examples, it was found that the cell viability of examples 6 and 7 was more than 70%, and the cells were judged to be low in irritation.
[ irritation test ]: patch test
The 24-hour closed patch test was performed according to an ethical committee approved protocol.
(1) Test method
The test samples were sealed and attached to the inner side of the upper arm of 10 subjects who had informed the content of the human body patch test profile and obtained written consent for 24 hours, the tape was peeled off after 24 hours, the first judgment was made after 60 minutes (after 24 hours), and the second judgment was made after 24 hours (after 48 hours).
(2) Determination criterion
The reference photograph (Hehe, visual Dermatology,3 (1), 74-81, 2004) was referred to for determination, the skin irritation index was calculated from the scores of table 9, and the skin irritation index of 5.0 or less was determined as low irritation based on table 10.
TABLE 9
Determination criterion for irritation test (patch test)
Determination of | Scoring of | Reaction |
- | 0 | No reaction |
± | 0.5 | Slight erythema |
+ | 1.0 | Erythema (red spot) |
++ | 2.0 | Erythema and edema |
+++ | 3.0 | Erythema + edema + papule + serous papule, small blister |
++++ | 4.0 | Bulla |
Japanese reference: chuan village et al, journal of Japanese dermatology 8- (5), 301-314, 1970
(calculation of skin irritation index)
The commercial percentage obtained by dividing the total score of each test sample by the number of subjects was expressed based on the scores after 24 hours and 48 hours of application of the adhesive tape, and the higher value was used as the skin irritation index.
TABLE 10
Calculation of skin irritation index for irritation test (Patch test)
Shellfish, cosmetic chemistry, 19, temporary journal of journal, 49-56, 1995
Example 6 Low irritation cosmetic
The patch test was performed on example 6, which is a cosmetic containing the preservative of the present invention shown in table 11, and the evaluation results are shown in table 11.
TABLE 11
From the evaluation results of examples, the skin irritation index of example 6 was 0, and it was determined that the skin irritation was low.
Industrial applicability
A low-irritation cosmetic excellent in preservative property which can be used by a user of sensitive skin is provided.
Claims (4)
1. A preservative promoter comprises at least 3 or more preservatives other than phenoxyethanol, parahydroxybenzoate and 1, 2-hexanediol.
2. The preservative accelerator according to claim 1, wherein the preservative is at least 3 or more selected from the group consisting of pentanediol, ethylhexyl glycerol, 1, 3-butanediol, caprylic acid glyceride, and bisabolol.
3. A low irritation cosmetic comprising the preservative accelerator according to claim 1 or 2, free of phenoxyethanol, parahydroxybenzoate and 1, 2-hexanediol.
4. A method for producing the low-irritation cosmetic according to claim 3.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022002557A JP2023102152A (en) | 2022-01-11 | 2022-01-11 | Low-irritant cosmetic |
JP2022-002557 | 2022-01-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116421485A true CN116421485A (en) | 2023-07-14 |
Family
ID=87082089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310025885.XA Pending CN116421485A (en) | 2022-01-11 | 2023-01-09 | Low-irritation cosmetic |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP2023102152A (en) |
CN (1) | CN116421485A (en) |
-
2022
- 2022-01-11 JP JP2022002557A patent/JP2023102152A/en active Pending
-
2023
- 2023-01-09 CN CN202310025885.XA patent/CN116421485A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2023102152A (en) | 2023-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102587334B1 (en) | Strains for improving skin, and kit for improving skin using the same | |
JP4418976B2 (en) | Antiseptic disinfectant and cosmetic composition | |
US10721937B1 (en) | Preservative systems and compositions and methods incorporating same | |
EP2883549B1 (en) | Antimicrobial composition comprising filobasidium-suppressing agent derived from natural substance | |
CN109152716A (en) | Taurine and aloe collaboration anti-irritant composition and method | |
KR101917774B1 (en) | A preservative composition of cosmetics comprising Nigella sativa seed extract as an active ingredient | |
US20160317420A1 (en) | Method of improving the appearance of skin and compositions therefor | |
KR20140053996A (en) | Use of sphinganine to improve the visual appearance of skin and hair | |
CN106511136A (en) | Moisturizing cosmetic additive and preparation method thereof and cosmetics containing moisturizing cosmetic additive | |
IL246041A (en) | Exfoliative hair retention-promoting formulation | |
KR102272901B1 (en) | Composition for external application to the skin containing meso-2,3-butanediol as a preservative | |
KR20090054777A (en) | Composition for controlling ph of skin and cosmetics comprising the same | |
US20200129393A1 (en) | Antiperspirant / Deodorant Composition | |
JP2004352688A (en) | Antiseptic agent | |
KR101702648B1 (en) | A preservative for skin external application, and a cosmetic composition and a pharmaceutical composition comprising the same | |
EP1593371B1 (en) | Acid buffered skin or hair care composition | |
CN116421485A (en) | Low-irritation cosmetic | |
CN115040463A (en) | Anti-wrinkle whitening composition | |
US10682301B2 (en) | Use of 4-(3-ethoxy-4-hydroxyphenyl)alkylketone as a skin-soothing agent | |
JP5072930B2 (en) | Antiseptic disinfectant and cosmetic composition | |
KR20160048648A (en) | Low irritation skin external application composition with an improved antiseptic ability | |
US20190142718A1 (en) | Novel use | |
CN110141526B (en) | Moisturizing and anti-wrinkle emulsion and preparation method thereof | |
CN117679321A (en) | Composition with synergistic acne removal effect and application thereof | |
CN116869863A (en) | Oil-control pre-makeup isolation emulsion and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication |